コンテンツへスキップ
Merck

Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.

Bioorganic & medicinal chemistry letters (2006-03-24)
Balasubramanian Narasimhan, Vishnukant Mourya, Avinash Dhake
要旨

A series of esters and amides of myristic acid was synthesized and tested in vitro for antibacterial activity against gram-positive and gram-negative bacteria. All the compounds showed activity comparable to that of the standard drug, ciprofloxacin. The structural characteristics governing antibacterial activity of myristic acid derivatives was studied using QSAR methodology. The results showed that the antibacterial activity could be modeled using the topological descriptor, valence molecular connectivity index. The predictive ability of the models was cross-validated by construction of a test set. The low residual activity and high cross-validated r2 values (r(cv)2) observed indicated the predictive ability of the developed QSAR models.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ミリスチン酸イソプロピル, 98%
Sigma-Aldrich
シプロフロキサシン, ≥98% (HPLC)
Sigma-Aldrich
ミリスチン酸メチル, ≥99% (GC)
Sigma-Aldrich
ミリスチン酸, Sigma Grade, ≥99%
Sigma-Aldrich
ミリスチン酸イソプロピル, ≥90% (GC)
Supelco
ミリスチン酸メチル, analytical standard
Sigma-Aldrich
ミリスチン酸イソプロピル, ≥98%
Sigma-Aldrich
ミリスチン酸エチル, ≥98%, FCC, FG
Sigma-Aldrich
ミリスチン酸メチル, ≥98%, FG
Supelco
シプロフロキサシン, VETRANAL®, analytical standard
Sigma-Aldrich
ミリスチン酸, ≥98.0% (GC)
Sigma-Aldrich
ミリスチン酸, ≥95%, FCC, FG
Sigma-Aldrich
ミリスチン酸, natural, ≥98.5%, FG
Supelco
ミリスチン酸, analytical standard
Sigma-Aldrich
ミリスチン酸エチル, 99% (GC)